Non Injectable Insulin Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0089812
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare non injectable insulin market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:8.14
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 8.14
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Report Scope:

The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The report discusses strategies adopted by emerging market players, with recommendations for new market entrants. This research study discusses historical, current and potential market size. The report will help market players and new entrants make informed decisions about the production and export of goods and services. Organizations, distributors and exporters should find the information about market development and trends useful. The study segments the market according to applications and end uses. Geographical market analysis is provided for all major segments.

Report Includes:

- An overview of the global market for non-injectable insulin
- Analyses of market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on recent major technical advances in different forms of non-injectable insulin
- A look at the key areas of growth and adoption rate of non-injectable insulin among both commercial customers and regulatory authorities
- Examination of strategies of the major players in the market and the impact of new technological developments

Summary

This comprehensive report provides an in-depth assessment of the global market for Non-injectable insulin. The report’s key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of Non-injectable insulin in developed and emerging markets.

This report details recent key technical advances in different forms of Non-injectable insulin, as well as the adoption rate among both commercial customers and regulatory authorities. The report intends to identify key areas of growth. The report also studies the key strategies of major players in the market and the impact of new technological developments.

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Future Market Potential and Investment Analysis
North America Will be the Largest and Fastest-Growing Market
Chapter 4 Market Breakdown by Form
Pills
Spray
Others (Film and Chewing Gum)
Chapter 5 Market Breakdown by Source
Synthetic Insulin
Semisynthetic Insulin
Chapter 6 Market Breakdown by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Chapter 7 Competitive Landscape
Chapter 8 Company Profiles
ACCESS PHARMACEUTICALS INC. (ABEONA THERAPEUTICS INC.)
AERAMI THERAPEUTICS
BIOCON LTD.
BIODEL INC. (ALBIREO LTD.)
BIONOVA LIFESCIENCES
BOSTON THERAPEUTICS INC.
COROMED INC.
DIABETOLOGY LTD.
DIASOME PHARMACEUTICALS INC.
EMISPHERE TECHNOLOGIES INC.
GENEREX BIOTECHNOLOGY CORP.
MIDATECH PHARMA PLC
ORAMED PHARMACEUTICALS INC.
RANI THERAPEUTICS
SHREYA LIFE SCIENCES PVT. LTD.

List of Tables
Summary Table : Global Market for Non-injectable Insulin, by Region, Through 2024
Table 1 : Other Products Related to Non-injectable Insulin
Table 2 : Examples of Non-injectable Insulin Products
Table 3 : Global Market for Non-injectable Insulin, by Form, Through 2024
Table 4 : Global Market for Edible Insulin Pills, by Region, Through 2024
Table 5 : Global Market for Insulin Sprays, by Region, Through 2024
Table 6 : Global Market for Other Forms of Non-injectable Insulin, by Region, Through 2024
Table 7 : Global Market for Non-injectable Insulin, by Source, Through 2024
Table 8 : Global Market for Synthetic Non-injectable Insulin, by Region, Through 2024
Table 9 : Global Market for Semisynthetic Non-injectable Insulin, by Region, Through 2024
Table 10 : Global Market for Non-injectable Insulin, by Region, Through 2024
Table 11 : Top 10 Countries with the Highest Prevalence of Diabetes Across the Globe, 2019
Table 12 : North American Market for Non-injectable Insulin, by Form, Through 2024
Table 13 : North American Market for Non-injectable Insulin, by Source, Through 2024
Table 14 : Prevalence of Diabetes in North American Countries, 2010-2017
Table 15 : Prevalence of Diabetes in North America, 2019-2045
Table 16 : Prevalence of Diabetes in Europe, 2019-2045
Table 17 : European Market for Non-injectable Insulin, by Form, Through 2024
Table 18 : European Market for Non-injectable Insulin, by Source, Through 2024
Table 19 : Existing National Diabetes Plans in Europe, by Country
Table 20 : Prevalence of Diabetes in Asia-Pacific, 2019-2045
Table 21 : Asia-Pacific Market for Non-injectable Insulin, by Form, Through 2024
Table 22 : Asia-Pacific Market for Non-injectable Insulin, by Source, Through 2024
Table 23 : Rest of the World Market for Non-injectable Insulin, by Form, Through 2024
Table 24 : Rest of the World Market for Non-injectable Insulin, by Source, Through 2024

List of Figures
Summary Figure : Global Market for Non-injectable Insulin, by Region, 2018-2024
Figure 1 : Global Prevalence of Diabetes in the 20-79 Year Age Group, 2011-2045*
Figure 2 : Global Diabetes Prevalence, 2019-2045
Figure 3 : Novo Nordisk Revenue Share, by Region, 2018
Figure 4 : Eli Lilly Revenue Share, by Segment, 2018
Figure 5 : Nektar Therapeutics Revenue Share, by Region, 2018

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"